Healthcare Sector

JNJ

Market Tracker

$177.59
-0.54
(-0.30%)
9:24 am
Next Earnings: (est.) 07/20/23 12:00 am
  • JNJ (Selected)

    Johnson & Johnson

JNJ Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

JNJ Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

JNJ Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

JNJ Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

JNJ Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

JNJ Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
11/21/2025 CALL $190.00 11,404 +10,001 +712.83%
10/17/2025 CALL $185.00 3,219 +492 +18.04%
09/12/2025 CALL $182.50 1,089 +337 +44.81%
09/12/2025 CALL $180.00 1,881 +227 +13.72%
10/17/2025 PUT $170.00 4,105 +156 +3.95%
09/12/2025 PUT $175.00 2,323 +139 +6.36%
11/21/2025 CALL $175.00 5,795 -53 -0.91%
11/21/2025 CALL $185.00 3,375 -58 -1.69%
09/19/2025 CALL $190.00 1,588 -67 -4.05%
12/19/2025 PUT $160.00 552 -76 -12.10%
06/18/2026 CALL $190.00 548 -82 -13.02%
10/17/2025 CALL $175.00 14,446 -861 -5.62%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

JNJ Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.55% 79.47M 12.56B
Vanguard 500 Index Fund 1.94% 60.44M 9.55B
Fidelity 500 Index Fund 0.92% 28.66M 4.53B
SPDR S&P 500 ETF Trust 0.91% 28.31M 4.47B
iShares Core S&P 500 ETF 0.75% 23.33M 3.69B
Vanguard Index-Value Index Fund 0.72% 22.6M 3.57B
Select Sector SPDR Fund-Health Care 0.68% 21.24M 3.36B
Vanguard Institutional Index Fund-Institutional Index Fund 0.59% 18.32M 2.9B
Vanguard Specialized-Dividend Appreciation Index Fund 0.53% 16.62M 2.63B
Washington Mutual Investors Fund 0.40% 12.37M 1.96B

JNJ News

  • Numab Therapeutics Announces Leadership Transition and Appoints Angehrn Pavik as Chief Executive Officer

    09/09 08:00 am

    GlobeNewswire Inc.

    Read more
  • Data published in The New England Journal of Medicine demonstrate RYBREVANT®▼(amivantamab) plus LAZCLUZE®▼ (lazertinib) could re-set survival expectations in first-line EGFR-mutated advanced lung cancer

    09/07 03:28 am

    GlobeNewswire Inc.

    Read more
  • RYBREVANT®▼ (amivantamab) plus LAZCLUZE®▼ (lazertinib) reduces acquired resistance versus osimertinib in first-line EGFR-mutated advanced non-small cell lung cancer

    09/06 03:10 am

    GlobeNewswire Inc.

    Read more
  • Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight

    09/04 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Software Automation in Research and Development (R&D) Clinical Trials Training Course | Harnessing Automation Technology to Deliver Faster, Cost-Effective Outcomes (Oct 1, 2025)

    09/04 10:00 am

    GlobeNewswire Inc.

    Read more
  • Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?

    09/04 04:09 am

    The Motley Fool

    Read more
  • Multiple Myeloma Market Size Projected USD 49.89 Billion by 2034

    09/03 11:00 am

    GlobeNewswire Inc.

    Read more
  • Healthcare Valuations Near Multi-Year Lows Suggest Risk–Reward Asymmetry

    09/02 09:37 am

    Investing.com

    Read more
  • Grand River Aseptic Manufacturing (GRAM) Appoints Denis Johnson as Chief Executive Officer

    09/02 09:00 am

    GlobeNewswire Inc.

    Read more
  • Acne Medicine Market Size Projected to Reach USD 23.33 Billion by 2034

    09/01 10:00 am

    GlobeNewswire Inc.

    Read more
  • These 4 Dividend Stocks Are Money-Printing Machines

    08/31 02:10 pm

    The Motley Fool

    Read more
  • Dermatology Market to Worth USD 2.75 Billion Size by 2034

    08/29 11:00 am

    GlobeNewswire Inc.

    Read more
  • SGLT2 Inhibitors Market to Hit USD 29.73 Billion by 2032, Driven by Expanding Diabetes Management and Cardiovascular Benefits – SNS Insider

    08/29 09:00 am

    GlobeNewswire Inc.

    Read more
  • Global Pharmaceuticals Market to Register Immense Growth at a CAGR of ~7% by 2032 | DelveInsight

    08/27 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Maxion Therapeutics Strengthens Board with Appointment of Dr. Santiago Arroyo as a Non-Executive Director

    08/27 08:00 am

    GlobeNewswire Inc.

    Read more
  • Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma

    08/27 04:50 am

    GlobeNewswire Inc.

    Read more
  • As the Market Rotates, This Healthcare ETF Is Leading the Way

    08/26 10:07 am

    Investing.com

    Read more
  • Should You Buy Intuitive Surgical Stock Today, or Wait for a Better Price?

    08/25 05:11 am

    The Motley Fool

    Read more
  • Got $500? 3 Dividend Stocks to Buy and Hold Forever

    08/25 04:04 am

    The Motley Fool

    Read more
  • Global Surgical Sutures Market Poised to Reach USD 6.65 Billion by 2030 | MarketsandMarkets™

    08/22 08:00 am

    GlobeNewswire Inc.

    Read more
  • Global Tissue Engineering and Regeneration Market Set to Surge at 12.8% CAGR Through 2030

    08/19 01:54 pm

    GlobeNewswire Inc.

    Read more
  • Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm

    08/17 07:23 pm

    The Motley Fool

    Read more
  • These Are the 3 Smartest Dividend Stocks Today

    08/16 10:30 am

    The Motley Fool

    Read more
  • 3 Mega-Caps That Outperformed Expectations This Earnings Season

    08/14 11:03 am

    Investing.com

    Read more
  • MeiraGTx Sales Jump 1,133 Percent

    08/14 08:31 am

    The Motley Fool

    Read more
  • If You're In Your 20's, Consider Buying These 3 Healthcare Stocks

    08/13 06:05 am

    The Motley Fool

    Read more
  • Vicarious Surgical Narrows Loss in Q2

    08/12 10:29 pm

    The Motley Fool

    Read more
  • 3 Big Dividend Plays With Strong Earnings to Back Them

    08/11 12:21 pm

    Investing.com

    Read more
  • Novartis' Investigational Drug Aces Two Pivotal Trials For Chronic Disease Impacting Tears, Saliva

    08/11 09:53 am

    Benzinga

    Read more
  • 5 Dividend Stocks to Hold for the Next 5 Years

    08/09 06:14 pm

    The Motley Fool

    Read more
  • Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep

    08/08 09:05 am

    Benzinga

    Read more
  • Spinal Fusion Devices Market Outlook Report 2025-2029: Revenues to Grow by $2.9 Billion Driven by Rising Spinal Disorders, Technological Advances, and Increasing Device Launches

    08/08 04:49 am

    GlobeNewswire Inc.

    Read more
  • RxSight (RXST) Q2 Loss Beats Estimates

    08/07 06:23 pm

    The Motley Fool

    Read more
  • Protagonist (PTGX) Q2 Revenue Falls 26%

    08/07 12:34 am

    The Motley Fool

    Read more
  • Contineum (CTNM) Q2 R&D Jumps 78%

    08/05 11:34 pm

    The Motley Fool

    Read more
  • AAV for the Hereditary Retinal Diseases Clinical Trial Pipeline Analysis Demonstrates 70+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

    08/05 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Hematologist Dissatisfaction with Current Warm Autoimmune Hemolytic Anemia (w-AIHA) Treatment Spurs Interest in Late-Stage Pipeline, According to Spherix Global Insights

    07/29 01:51 pm

    GlobeNewswire Inc.

    Read more
  • 2 Unstoppable Dow Dividend Stocks to Buy and Hold Forever

    07/28 08:29 pm

    The Motley Fool

    Read more
  • These 3 Dow Stocks Are Set to Soar in 2025 and Beyond

    07/27 03:15 am

    The Motley Fool

    Read more
  • Oncology Drugs Market Insights, Competitive Landscape, and Forecast Report 2025-2032 | Immunotherapy Leads Growth in Oncology Market Due to Better Precision and Fewer Side Effects

    07/25 10:50 am

    GlobeNewswire Inc.

    Read more
  • AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate

    07/24 01:08 pm

    Benzinga

    Read more
  • Global Dysmenorrhea Treatment Market to Cross ~USD 8 Billion by 2032 | DelveInsight

    07/23 01:00 pm

    GlobeNewswire Inc.

    Read more
  • 4 Major Stocks Raise 2025 Guidance, Analyst Targets Rise

    07/23 08:37 am

    Investing.com

    Read more
  • Ipsen announces changes to its Executive Committee

    07/23 01:30 am

    GlobeNewswire Inc.

    Read more
  • Ipsen annonce des changements au sein de son Comité Exécutif

    07/23 01:30 am

    GlobeNewswire Inc.

    Read more
  • Bispecific Antibodies Market Set to Surge to $163.15 Billion by 2032, Driven by a Robust 40.1% CAGR | Roche, Amgen, and Johnson & Johnson at the Forefront: AnalystView Market Insights

    07/22 03:20 am

    GlobeNewswire Inc.

    Read more
  • 10 Magnificent S&P 500 Dividend Stocks Down Over 10% to Buy and Hold Forever

    07/20 05:01 am

    The Motley Fool

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: